Literature DB >> 9679047

Endothelin A-receptor blockade worsens endotoxin-induced hepatic microcirculatory changes and necrosis.

T Nishida1, T P Huang, A Seiyama, E Hamada, W Kamiike, S Ueshima, H Kazuo, H Matsuda.   

Abstract

BACKGROUND & AIMS: Endothelin 1 is considered to be an important regulator of sinusoidal blood flow and increases during endotoxemia. The purpose of this study was to investigate the role of endothelin 1 in hepatic microcirculation, oxygen transport, and liver injury during endotoxemia.
METHODS: Male Sprague-Dawley rats were continuously infused with 2.5 mL/h of saline, 0.8 mg . kg-1 . h-1 of lipopolysaccharide (LPS), 3 mg . kg-1 . h-1 of BQ-485, an endothelin A-receptor antagonist, or LPS plus BQ-485 for 7 hours.
RESULTS: BQ-485 infusion had no significant effect on hepatic microcirculation and liver injury. LPS increased the plasma levels of aspartate aminotransferase (AST) and total bilirubin and decreased the hepatic adenosine triphosphate (ATP) level and bile flow rate. LPS + BQ-485 infusion further increased the plasma levels of AST and total bilirubin and decreased the bile flow rate and the hepatic ATP level. Dual-spot microspectroscopy revealed mild decreases in sinusoidal erythrocyte velocity and oxygen transport in the LPS group and profound decreases in these parameters in the LPS + BQ-485 group. Histological examinations revealed massive necrotic changes in the pericentral regions of the LPS + BQ-485 group.
CONCLUSIONS: These results suggest that blockade of endothelin A receptors disturbs hepatic microcirculation and oxygen transport and aggravates the necrotic injury induced by endotoxin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9679047     DOI: 10.1016/s0016-5085(98)70208-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

1.  Effects of hypoxia, hyperoxia on the regulation of expression and activity of matrix metalloproteinase-2 in hepatic stellate cells.

Authors:  P S Chen; W R Zhai; X M Zhou; J S Zhang; Y E Zhang; Y Q Ling; Y H Gu
Journal:  World J Gastroenterol       Date:  2001-10       Impact factor: 5.742

2.  Endotoxin causes up-regulation of endothelin receptors in cultured hepatic stellate cells via nitric oxide-dependent and -independent mechanisms.

Authors:  C R Gandhi; T Uemura; R Kuddus
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  Differentiated effects on splanchnic homeostasis by selective and non-selective endothelin receptor antagonism in porcine endotoxaemia.

Authors:  A Oldner; M Wanecek; E Weitzberg; P Sundin; A Sollevi; C Rubio; P M Hellström; K Alving; A Rudehill
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

4.  Enhanced expression of endothelin B receptor at protein and gene levels in human cirrhotic liver.

Authors:  H Yokomori; M Oda; Y Yasogawa; Y Nishi; M Ogi; M Takahashi; H Ishii
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

5.  Endothelin receptor antagonist TAK-044 arrests and reverses the development of carbon tetrachloride induced cirrhosis in rats.

Authors:  C Thirunavukkarasu; Y Yang; V M Subbotin; S A K Harvey; J Fung; C R Gandhi
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

6.  Tezosentan, an endothelin receptor antagonist, limits liver injury in endotoxin challenged cirrhotic rats.

Authors:  W Urbanowicz; P Sogni; R Moreau; K A Tazi; E Barriere; O Poirel; A Martin; M C Guimont; D Cazals-Hatem; D Lebrec
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.